Drug intelligence / Profile preview

ciprofloxacin + fluocinolone acetonide

Development stage
Approved
Lead developer
Laboratorios Salvat
Modality
Small Molecules
Administration
Otic
01

Overview

**Ciprofloxacin + fluocinolone acetonide** is a fixed-dose otic antibacterial and corticosteroid combination. Ciprofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, causing bactericidal disruption of bacterial DNA replication. Fluocinolone acetonide is a glucocorticoid receptor agonist that suppresses local inflammatory signaling. The combination is supplied as a 0.3%/0.025% otic solution, including brands such as Otovel and Cetraxal Plus, for bacterial ear infections including acute otitis media with tympanostomy tubes and, in certain markets, acute otitis externa.

Brand names
Aceoto PlusBonadixCetraxalCetraxal CompCetraxal PlusInfectoCiproCortInfalin DuoOtovelSynalotic
Other names
ciprofloxacin + fluocinolone acetonideciprofloxacin and fluocinolone acetonideciprofloxacin hydrochloride + fluocinolone acetonideciprofloxacin/fluocinolone acetonide
02

Targets

GR (Glucocorticoid receptor)DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on ciprofloxacin + fluocinolone acetonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciprofloxacin + fluocinolone acetonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call